Vitamin D for Enhancing the Immune System in Cystic Fibrosis (DISC Study)

PHASE3CompletedINTERVENTIONAL
Enrollment

91

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

April 30, 2017

Study Completion Date

July 31, 2017

Conditions
Cystic FibrosisRespiratory Tract Infections
Interventions
DIETARY_SUPPLEMENT

Cholecalciferol

Bolus dose of 250,000 IU during hospitalization + maintenance dose of 50,000 IU vitamin D every other week to be initiated 3 months after bolus dose

Trial Locations (5)

30322

Emory Hospital, Atlanta

35233

University of Alabama at Birmingham, Birmingham

44106

Case Western Reserve University, Cleveland

45267

University of Cincinnati, Cincinnati

52242

University of Iowa, Iowa City

All Listed Sponsors
collaborator

Cystic Fibrosis Foundation

OTHER

lead

Emory University

OTHER

NCT01426256 - Vitamin D for Enhancing the Immune System in Cystic Fibrosis (DISC Study) | Biotech Hunter | Biotech Hunter